With all this technology, you’d have thought that apps were advanced enough to detect health dangers. However, this unfortunately may not be the case for many smartphone health apps.
We as Group Action Lawyers represent victims for Medical Group Actions and Data Breach Group Actions, so this is right up our avenue of experience.
Continue Reading…
Valproate Semisodium, better known as Depakote, has reportedly put more than 10,000 pregnant women at risk in France, and there are raising concerns that the same amount of women in the U.K. may also be affected by the epilepsy drug.
Our Group Action Lawyers are investigating the issues, and anyone affected here in the U.K. is free to come forward for confidential and no obligation advice.
Continue Reading…
The Stockert 3T heater-coolers used during certain surgeries have been linked to a dangerous microorganism, Mycobacterium chimaera.
The manufacturers of the ‘deadly device’ have now issued advice in relation to managing and cleaning the device as part of ongoing investigations.
Continue Reading…
Since its introduction into the market, the Medtronic infusion pump has been apparently overwhelmed with problems.
In recent years, problems that have been linked to the use of the pumps have reportedly caused dozens of deaths. As such, health authorities and the manufactures are in the process of taking appropriate action, and we’ll be looking in to whether there is any negligence here.
Continue Reading…
Birmingham surgeon Dr. Angamuthu Arunkalaivanan performed hundreds of the pelvic floor surgeries using a mesh implant that the Trust he worked for had banned from using.
Dr. Arunkalaivanan seemingly ignored the Trust’s instructions and carried on inserting these mesh implants into hundreds of women despite the warnings from the National Institute for Health and Care Excellence (NICE) of incontinence and infection, and his own Trust’s policy on their use.
Some 200 patients who have undergone pelvic floor surgeries with Dr. Arunkalaivanan have been recalled to be checked. However, pelvic floor operations are so routine that it may be many more than 200 woman affected by the surgeons actions.
Continue Reading…
A stern warning for all patients prescribed the blood-thinning drug Rivaroxaban; sold under the name of Xarelto, that’s available on the NHS:
Due to a battery issue, medical equipment like implantable cardioverter defibrillators (ICD) and cardiac resynchronisation therapy devices (CRT-D) have reportedly failed, leading to serious concerns for patient health.
It’s thought that around 350,000 devices worldwide have been implanted and potentially put patient health at risk.
Continue Reading…
Recent reports indicate that individuals taking medication known as beta-blockers and calcium antagonists for a period of more than 90 days may be susceptible to mood disorders that require hospital treatment.
These medications – commonly used to control blood pressure – are said to be a possible cause for major depression and / or bipolar disorder, drawn from comparisons with patients controlling their high blood pressure with angiotensin receptor blockers (ARBs) instead.
Continue Reading…
Teva UK Limited are one of the latest pharmaceutical manufacturers that have recalled a batch of their drugs.
The Nacrez 75 mg film-coated tablets have been recalled due to impurities found as part of their routine testing. The recall is said to be a precautionary measure taken by the company to ensure the safety of their customers.
However, as with any medicine recall, the dangers to human health are always something to closely monitor.
Continue Reading…
There are growing concerns surrounding the use of a particular type of heater-cooler system, Stockert 3T, manufactured by LivaNova, which are machines used during a patient’s surgery that have allegedly led to a spate of infections.
This was reportedly the case for Kenneth Piechowski, a Philadelphia man, when he had a surgery to replace a faulty aortic valve back in December 2014.
Continue Reading…
Tracheoesophageal voice devices have been reported to have a smaller life span than first anticipated.
What was thought to be at least a six month life span recently turned out to be only three months. This is a cause for concern as it could cause greater healthcare costs and a burden for the users who need to keep replacing them.
Continue Reading…
A Medical Device Alert has been issued with the Medicines and Healthcare products Regulatory Agency (MHRA) for the Accu-Chek Insight insulin pump system using NovoRapid PumpCart cartridges which is reportedly prone to leakage.
Leakage of the devices, manufactured by Roche Diabetes Care, could lead to serious consequences for users, which could include hyperglycaemia, diabetic ketoacidosis, or even death.
Continue Reading…